Rochelle Walensky, MD, MPH, is the director of the Division of Infectious Diseases at Massachusetts General Hospital and a professor of medicine at Harvard Medical School.
Walensky worked in the field of HIV/AIDS research and is considered one of the top authorities in the country on virus testing, mitigation, and treatment.
Walensky also worked on the COVID-19 pandemic in Massachusetts, conducting studies on vaccine delivery and outreach methods for underserved populations.
That could be why Joe Biden was directed to choose Walensky to lead the Centers for Disease Control and Prevention.
The departing director of the CDC testified before the Select Subcommittee on the Coronavirus Pandemic on Tuesday in what was probably her final appearance before Congress before she exits at the close of the month.
House Republicans gave Walensky a scathing send-off.
Republican senators grilled Walensky severely throughout the meeting because they were tired of her contradictory and false claims regarding the effectiveness of vaccines in halting the spread of COVID-19.
When questioned by Rep. Jim Jordan, Walensky responded that her assertions about the effectiveness of vaccines were generally true.
“CDC Director Rochelle Walensky Says Her Vaccine Effectiveness Claims Were ‘Generally Accurate’
“We generally saw that if you were to get infected after you had been vaccinated that you were not carrying the virus by transmitting it to somebody else. You could not transmit it to others.””
CDC Director Rochelle Walensky Says Her Vaccine Effectiveness Claims Were 'Generally Accurate'
"We generally saw that if you were to get infected after you had been vaccinated that you were not carrying the virus by transmitting it to somebody else. You could not transmit it to… pic.twitter.com/5JOqcalLwK
— Chief Nerd (@TheChiefNerd) June 13, 2023
Rep. Marjorie Taylor Greene grilled Walensky about her professional goals after leaving the CDC in an equally direct line of questions.
“Now that you’re going to be leaving the CDC pretty soon, what job are you going to take? Are you going to be on the board of either Pfizer or Moderna because you’ve done one hell of a job in making sure that they’ve made a lot of money,” Greene questioned.
🔥 MTG Asks CDC Director Rochelle Walensky Which Vaccine Company She is Going to Work For After She Leaves the CDC
"Now that you're going to be leaving the CDC pretty soon, what job are you going to take? Are you going to be on the board of either Pfizer or Moderna because… pic.twitter.com/K9mUwIrtJ8
— Chief Nerd (@TheChiefNerd) June 13, 2023
The most memorable exchange of blows during the hearing may have occurred even before the formal hearings began. Former Green Beret and attorney Ivan Raiklin directly disputed Walensky.
“Hey, Dr. Walensky. I really look forward to you testifying about your involvement in the deaths of 38,000 Americans due to the jab,” Raiklin said sarcastically.
“One of the key future Nuremburg 2.0 defendants who committed EUA Product genocide enters the room. Listen closely.”
One of the key future Nuremburg 2.0 defendants who committed EUA Product genocide enters the room. Listen closely. pic.twitter.com/vJC8MW9LOw
— Ivan Raiklin (@IvanRaiklin) June 13, 2023
38k number comes from the CDC's own VAERS database. pic.twitter.com/LOz8RKnFjU
— Ivan Raiklin (@IvanRaiklin) June 14, 2023
Earlier this year, a COVID-19 epidemic occurred during a conference hosted by the U.S. Centers for Disease Control and Prevention (CDC).
In April, over 1,800 CDC employees and others met in Atlanta, where the CDC is based, at a hotel for a meeting on epidemiological research and tactics.
Several attendees informed conference organizers that they had come up positive for COVID-19 on April 27, the conference’s final day. In an effort to determine the proportion of guests who had tested positive, the CDC and the Georgia Department of Public Health conducted a survey of registrants.
The CDC stated in an announcement on May 26 that the objectives of the study were to “learn more about the transmission that occurred and add to our understanding as we transition to the next phase of COVID-19 surveillance and response.”
About 80% of participants responded to the survey. 181 of them claimed to have tested positive for COVID-19.
99.4% of the respondents reported receiving at least one dose of the COVID-19 vaccination.
If any unvaccinated individuals become ill, the number of cases was not made public. Additionally, officials did not distinguish between those who had been immunized with the latest bivalent vaccinations and those who had not. Requests for more information have not received a response from the CDC.
The survey was completed by about 360 persons, so the outbreak may have been more widespread than that.
The symposium was a “superspreader event,” according to Dr. Eric Topol, head of the Scripps Research Translational Institute, who posted the information on Twitter.
The outbreak demonstrates that COVID-19 is “still capable of causing big outbreaks and infecting many,” according to Dr. Tom Inglesby, head of the Johns Hopkins Center for Health Security at the Bloomberg School of Public Health.
A representative for the Georgia Department of Public Health informed The Epoch Times via email that many conference attendees were non-Georgians and that many of them used testing at home.
The CDC stated that the survey results “underline the importance of vaccination for protecting individuals against severe illness and death related to COVID-19” since none of the respondents who indicated they were positive reported visiting a hospital.
The bivalent shots have not yet undergone any clinical trials, despite the fact that they were initially approved nine months ago. Observational data indicate that they offer minimal defense against infection, despite the fact that authorities claim they offer defense against serious sickness. Studies, even those in CDC papers that have not undergone peer review, show that this protection is transient.
The Pfizer and Moderna bivalent COVID-19 vaccinations, which replaced the previous vaccines earlier this year, had inadequate efficiency against hospitalization, according to the most current publication, which was published on May 26.